drugset / Trial / NCT00799149
Etoricoxib Versus Gabapentin for Knee Arthroscopy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine that when administered as part of a multimodal analgesic regimen, use of the new COX-2 antagonist etoricoxib (120 mg/day, per os) is more effective in improving postoperative pain management after knee arthroscopy than gabapentin (1.2 g/day, per os).
Timeline
- Start
- 2006-06
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etoricoxib | Small molecule | 120 mg | Oral |
| Comparator | Gabapentin | Small molecule | 1200 mg | Oral |
Indications
No indication recorded.